HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $334,000 | +136.9% | 33,809 | +107.6% | 0.09% | +242.3% |
| Q2 2016 | $141,000 | -18.5% | 16,286 | -11.1% | 0.03% | +4.0% |
| Q1 2016 | $173,000 | -54.8% | 18,310 | -35.8% | 0.02% | -32.4% |
| Q3 2015 | $383,000 | -81.9% | 28,503 | -80.8% | 0.04% | -82.1% |
| Q1 2015 | $2,116,000 | +1013.7% | 148,179 | +610.2% | 0.21% | +1193.8% |
| Q3 2014 | $190,000 | -53.4% | 20,864 | -23.4% | 0.02% | -15.8% |
| Q4 2013 | $408,000 | -74.8% | 27,247 | -81.4% | 0.02% | -74.3% |
| Q3 2013 | $1,616,000 | +32.5% | 146,416 | -4.6% | 0.07% | +45.1% |
| Q2 2013 | $1,220,000 | – | 153,432 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |